Prepubertal physical activity up-regulates estrogen receptor β, BRCA1 and p53 mRNA expression in the rat mammary gland

Breast Cancer Research and Treatment

Volumn 115, Issue 1, 2009, Pages 213-220

  Wang, M ^a   Yu, B ^a   Westerlind, K ^b   Strange, R ^b   Khan, G ^a   Patil, D ^a   Boeneman, K ^a   Hilakivi Clarke, L ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

BRCA1; Estrogen receptor; P53; Prepubertal physical activity; Terminal end bud

Indexed keywords

BRCA1 PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; MAMMARY GLAND; MORPHOLOGY; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; STAINING; TREADMILL EXERCISE;

ALLELES; ANIMALS; BRCA1 PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION; GENES, BRCA1; GENES, P53; KI-67 ANTIGEN; MAMMARY GLANDS, ANIMAL; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67349157659     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0062-x     Document Type: Article

References (42)

1. CM Friedenreich KS Courneya HE Bryant 2001 Influence of physical activity in different age and life periods on the risk of breast cancer Epidemiology 12 604 612 10.1097/00001648-200111000-00005
2. YT Lagerros SF Hsieh CC Hsieh 2004 Physical activity in adolescence and young adulthood and breast cancer risk: a quantitative review Eur J Cancer Prev 13 5 12 10.1097/00008469-200402000-00002
3. MC King JH Marks JB Mandell 2003 Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 643 646 10.1126/science. 1088759
4. MW Hulver JA Houmard 2003 Plasma leptin and exercise: recent findings Sports Med 33 473 482 10.2165/00007256-200333070-00001
5. A McTiernan L Wu C Chen R Chlebowski Y Mossavar-Rahmani F Modugno 2006 Relation of BMI and physical activity to sex hormones in postmenopausal women Obesity (Silver Spring) 14 1662 1677 10.1038/oby.2006.191
6. SS Tworoger SA Missmer AH Eliassen RL Barbieri M Dowsett SE Hankinson 2007 Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women : Exercise and premenopausal hormones Cancer Causes Control 18 743 752 10.1007/s10552-007- 9017-5
7. KL Margolis L Mucci T Braaten M Kumle LY Trolle HO Adami 2005 Physical activity in different periods of life and the risk of breast cancer: the Norwegian-Swedish Women's Lifestyle and Health cohort study Cancer Epidemiol Biomarkers Prev 14 27 32
8. EM Monninkhof SG Elias FA Vlems I van der Tweel AJ Schuit DW Voskuil FE van Leeuwen 2007 Physical activity and breast cancer: a systematic review Epidemiology 18 137 157 10.1097/01.ede.0000251167.75581.98
9. K Steindorf M Schmidt S Kropp J Chang-Claude 2003 Case-control study of physical activity and breast cancer risk among premenopausal women in Germany Am J Epidemiol 157 121 130 10.1093/aje/kwf181
10. AC Antoniou DF Easton 2006 Models of genetic susceptibility to breast cancer Oncogene 25 5898 5905 10.1038/sj.onc.1209879
11. A Dobrovic D Simpfendorfer 1997 Methylation of the BRCA1 gene in sporadic breast cancer Cancer Res 57 3347 3350
12. E Matros ZC Wang G Lodeiro A Miron JD Iglehart AL Richardson 2005 BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles Breast Cancer Res Treat 91 179 186 10.1007/s10549-004-7603-8
13. Hoshino A, Yee CJ, Campbell M, Woltjer RL, Townsend RL, van der MR, Shyr Y, Holt JT, Moses HL, Jensen RA (2007) Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia. Int J Biol Sci 3:281-291
14. ST Marquis JV Rajan A Wynshaw-Boris J Xu GY Yin KJ Abel 1995 The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues Nat Genet 11 17 26 10.1038/ng0995-17
15. J Russo D Mailo YF Hu G Balogh F Sheriff IH Russo 2005 Breast differentiation and its implication in cancer prevention Clin Cancer Res 11 931s 936 s
16. PB Mullan JE Quinn DP Harkin 2006 The role of BRCA1 in transcriptional regulation and cell cycle control Oncogene 25 5854 5863 10.1038/sj.onc.1209872
17. SA Narod WD Foulkes 2004 BRCA1 and BRCA2: 1994 and beyond Nat Rev Cancer 4 665 676 10.1038/nrc1431
18. S Fan J-A Wang R Yuan Y Ma Q Meng MR Erdos 1999 BRCA1 inhibition of estrogen receptor signalling in transfected cells Science 284 1354 1356 10.1126/science.284.5418.1354
19. S Fan Y Xian Ma C Wang R Yuan Q Meng J-A Wang 2001 Role of direct interaction in BRCA1 inhibition of estrogen receptor activity Oncogene 20 77 87 10.1038/sj.onc.1204073
20. M Lacroix RA Toillon G Leclercq 2006 p53 and breast cancer, an update Endocr Relat Cancer 13 293 325 10.1677/erc.1.01172
21. JM Varley G McGown M Thorncroft MF Santibanez-Koref AM Kelsey KJ Tricker 1997 Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families Cancer Res 57 3245 3252
22. P Kleihues B Schauble HA Zur J Esteve H Ohgaki 1997 Tumors associated with p53 germline mutations: a synopsis of 91 families Am J Pathol 150 1 13
23. P Arizti L Fang I Park Y Yin E Solomon T Ouchi 2000 Tumor suppressor p53 is required to modulate BRCA1 expression Mol Cell Biol 20 7450 7459 10.1128/MCB.20.20.7450-7459.2000
24. M Schuyer EM Berns 1999 Is TP53 dysfunction required for BRCA1-associated carcinogenesis? Mol Cell Endocrinol 155 143 152 10.1016/S0303-7207(99) 00117-3
25. S Sengupta B Wasylyk 2004 Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors Ann N Y Acad Sci 1024 54 71 10.1196/annals.1321.005
26. J Russo BA Gusterson AE Rogers IH Russo SR Wellings MJ van Zwieten 1990 Comparative study of human and rat mammary tumorigenesis Lab Invest 62 244 278
27. J Russo IH Russo 1987 Biological and molecular bases of mammary carcinogenesis Lab Invest 57 112 137
28. RD Cardiff 1998 Are the TDLU of the human the same as the LA of mice? J Mammary Gland Biol Neoplasia 3 3 5 10.1023/A:1018714016205
29. RB Clarke A Howell CS Potten E Anderson 1997 Dissociation between steroid receptor expression and cell proliferation in the human breast Cancer Res 57 4987 4991
30. K Paech P Webb GG Kuiper JA Gustafsson PJ Kushner TS Scanlan 1997 Differential ligand activation of estrogen receptors Er alpha and ER beta at AP1 sites Science 277 1508 1510 10.1126/science.277.5331.1508
31. G Cheng Z Weihua M Warner JA Gustafsson 2004 Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland Proc Natl Acad Sci USA 101 3739 3746 10.1073/pnas.0307864100
32. EC Chang J Frasor B Komm BS Katzenellenbogen 2006 Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells Endocrinology 147 4831 4842 10.1210/en.2006-0563
33. CY Lin A Strom KS Li S Kietz JS Thomsen JB Tee 2007 Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer Breast Cancer Res 9 R25 10.1186/bcr1667
34. JA Gustafsson M Warner 2000 Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer J Steroid Biochem Mol Biol 74 245 248 10.1016/S0960-0760(00) 00130-8
35. L Hilakivi-Clarke R Clarke I Onojafe M Raygada E Cho ME Lippman 1997 A maternal diet high in n-6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring Proc Natl Acad Sci USA 94 9372 9377 10.1073/pnas.94.17.9372
36. WP Bocchinfuso KS Korach 1997 Mammary gland development and tumorigenesis in estrogen receptor knockout mice J Mammary Gland Biol Neoplasia 2 323 334 10.1023/A:1026339111278
37. Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, Parrish A et al (2007) Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene
38. X Xu KU Wagner D Larson Z Weaver C Li T Ried 1999 Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation Nat Genet 22 37 43 10.1038/8743
39. DJ Jerry C Kuperwasser SR Downing J Pinkas C He E Dickinson 1998 Delayed involution of the mammary epithelium in BALB/c-p53null mice Oncogene 17 2305 2312 10.1038/sj.onc.1202157
40. I Locke Z Kote-Jarai MJ Fackler E Bancroft P Osin A Nerurkar 2007 Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls Breast Cancer Res 9 R20 10.1186/bcr1657
41. G Strathdee A Sim R Soutar TL Holyoake R Brown 2007 HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia Carcinogenesis 28 299 309 10.1093/carcin/bgl133
42. ZH Meng Y Ben Z Li K Chew BM Ljung MD Lagios 2004 Aberrations of breast cancer susceptibility genes occur early in sporadic breast tumors and in acquisition of breast epithelial immortalization Genes Chromosomes Cancer 41 214 222 10.1002/gcc.20089